Literature DB >> 2893637

Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers.

J H Lin1, A N Chremos, R Chiou, K C Yeh, R Williams.   

Abstract

The comparative effect of famotidine or cimetidine on theophylline disposition was determined in healthy volunteers. Cimetidine, but not famotidine, caused a reduction in the rate of elimination of theophylline. The mean total body clearance of theophylline was reduced from 57.6 ml min-1 before cimetidine to 39.5 ml min-1 during cimetidine; and the half-life was prolonged from 8.7 h before cimetidine to 12 h during cimetidine. The volume of distribution and renal excretion of theophylline were not affected by either famotidine or cimetidine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893637      PMCID: PMC1386341          DOI: 10.1111/j.1365-2125.1987.tb03228.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Cimetidine interaction with warfarin.

Authors:  D Hetzel; D Birkett; J Miners
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

2.  Cimetidine interaction with phenytoin.

Authors:  D J Hetzel; F Bochner; J F Hallpike; D J Shearman; C S Hann
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09

Review 3.  Inhibition of oxidative drug metabolism in microsomes.

Authors:  K J Netter
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

4.  Decreased clearance of theophylline due to cimetidine.

Authors:  M M Weinberger; G Smith; G Milavetz; L Hendeles
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

5.  Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.

Authors:  P Mojaverian; M L Rocci; C L Saccar; P H Vlasses; R K Ferguson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

6.  MK-208, a novel histamine H2-receptor inhibitor with prolonged antisecretory effect.

Authors:  R W McCallum; A N Chremos; B Kuljian; M A Tupy-Visich; P B Huber
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

7.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

8.  Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.

Authors:  J M Howard; A N Chremos; M J Collen; K E McArthur; J A Cherner; P N Maton; C A Ciarleglio; M J Cornelius; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

9.  Comparative effects of H2-receptor antagonists on drug interaction in rats.

Authors:  J H Lin; D M Cocchetto; K C Yeh; D E Duggan
Journal:  Drug Metab Dispos       Date:  1986 Nov-Dec       Impact factor: 3.922

10.  Cimetidine impairs the elimination of theophylline and antipyrine.

Authors:  R K Roberts; J Grice; L Wood; V Petroff; C McGuffie
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

View more
  11 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers.

Authors:  A Wahlländer; G Paumgartner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 4.  Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 5.  Pharmacokinetic drug interactions with anti-ulcer drugs.

Authors:  R D Negro
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

Review 6.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of famotidine.

Authors:  H Echizen; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

8.  Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor.

Authors:  Vijay V Upreti; Yan Song; Jessie Wang; Wonkyung Byon; Rebecca A Boyd; Janice M Pursley; Frank Lacreta; Charles E Frost
Journal:  Clin Pharmacol       Date:  2013-04-16

9.  Extraneuronal monoamine transporter mediates the permissive action of cortisol in the Guinea pig trachea: possible involvement of tracheal chondrocytes.

Authors:  Chen Wang; Wenying Qiu; Yiqing Zheng; Hui Li; Yijia Li; Bing Feng; Shu Guo; Li Yan; Ji-Min Cao
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

10.  Volume of Distribution is Unaffected by Metabolic Drug-Drug Interactions.

Authors:  Jasleen K Sodhi; Caroline H Huang; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2021-02       Impact factor: 5.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.